• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

New for 2017!
Filter
Title Search
1 - 25 of 147 Products Sort by Display
Renal Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503694
Published
May 11, 2017
Content info
181 Pages
Price
USD 3995
Sample available
Women's Health Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503693
Published
May 10, 2017
Content info
123 Pages
Price
USD 3995
Sample available
Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503692
Published
May 9, 2017
Content info
139 Pages
Price
USD 3995
Sample available
Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503691
Published
May 8, 2017
Content info
79 Pages
Price
USD 3995
Sample available
CNS Cluster Addiction Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503690
Published
May 8, 2017
Content info
150 Pages
Price
USD 3995
Sample available
Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline
Published by
GBI Research
Product code
512859
Published
May 3, 2017
Content info
84 Pages
Price
USD 6995
Sample available
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
Published by
GBI Research
Product code
516017
Published
May 1, 2017
Content info
140 Pages
Price
USD 4995
Sample available
Frontier Pharma: Alzheimer's Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression
Published by
GBI Research
Product code
512858
Published
May 1, 2017
Content info
101 Pages
Price
USD 6995
Sample available
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market
Published by
GBI Research
Product code
498258
Published
April 1, 2017
Content info
176 Pages
Price
USD 4995
Sample available
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Published by
GBI Research
Product code
498257
Published
April 1, 2017
Content info
140 Pages
Price
USD 4995
Sample available
Antibacterial Therapies Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
485008
Published
March 22, 2017
Content info
418 Pages
Price
USD 3995
Sample available
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
489881
Published
March 21, 2017
Content info
797 Pages
Price
USD 3995
Sample available
Cardiovascular Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
485009
Published
March 16, 2017
Content info
432 Pages
Price
USD 3995
Sample available
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
358649
Published
March 9, 2017
Content info
161 Pages
Price
USD 4995
Sample available
Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products
Published by
GBI Research
Product code
493938
Published
March 2, 2017
Content info
76 Pages
Price
USD 6995
Sample available
Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets
Published by
GBI Research
Product code
493937
Published
March 1, 2017
Content info
126 Pages
Price
USD 4995
Sample available
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation
Published by
GBI Research
Product code
485007
Published
March 1, 2017
Content info
78 Pages
Price
USD 6995
Sample available
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market
Published by
GBI Research
Product code
485006
Published
March 1, 2017
Content info
197 Pages
Price
USD 4995
Sample available
Colorectal Cancer - Heat Map and Analysis
Published by
GBI Research
Product code
445728
Published
February 1, 2017
Content info
21 Pages
Price
USD 2000
Sample available
Parkinson's Disease - Heat Map and Analysis
Published by
GBI Research
Product code
440736
Published
January 9, 2017
Content info
20 Pages
Price
USD 2000
Sample available
Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance
Published by
GBI Research
Product code
440734
Published
January 9, 2017
Content info
177 Pages
Price
USD 4995
Sample available
Non-Hodgkin Lymphoma - Heat Map and Analysis
Published by
GBI Research
Product code
440735
Published
January 6, 2017
Content info
15 Pages
Price
USD 2000
Sample available
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
Published by
GBI Research
Product code
440733
Published
January 5, 2017
Content info
80 Pages
Price
USD 6995
Sample available
Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies
Published by
GBI Research
Product code
431673
Published
January 2, 2017
Content info
108 Pages
Price
USD 4995
Sample available
Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation
Published by
GBI Research
Product code
431672
Published
January 2, 2017
Content info
81 Pages
Price
USD 6995
Sample available